Latest Form 4 insider transactions

Peter A. Kidd, EVP and CHRO of Kontoor Brands, Inc., reported a transaction in 580 shares of common stock on August 14, 2026.

Willie Cw Chiang, Chairman & CEO and a Director of Plains All American Pipeline Lp, reported multiple transactions in common stock on August 13, 2026.

David Schellhase, a Director of Okta, Inc., reported multiple transactions in common stock on August 13, 2026.

Daniel Allen Gold, a Director of Okeanis Eco Tankers Corp., sold 76,959 shares of common stock on August 13, 2026.

Joseph Shulman, Chief Technical Officer of Rhythm Pharmaceuticals, Inc., sold 5,079 shares of common stock on August 13, 2026 for $119.75 per share.

David A. Beitel, Chief Technology Officer of Zillow Group, Inc., sold 1,798 shares of common stock on August 13, 2026 for $34.24 per share.

Gina Fitzsimons, See Remarks of Hexcel Corp /De/, sold 9,675 shares of common stock on August 14, 2026.

Matthew Fisch, CEO and a Director of AEye, Inc., reported a transaction in 40,242 shares of common stock on August 15, 2026.

Jennifer Rock, Chief Accounting Officer of Zillow Group, Inc., sold 990 shares of common stock on August 13, 2026 for $34.24 per share.

Errol G Samuelson, Chief Industry Dev. Officer of Zillow Group, Inc., sold 3,154 shares of common stock on August 13, 2026 for $34.24 per share.

Joseph Clay Thornton, Interim CFO of Clover Health Investments, Corp. /De, sold 17,775 shares of common stock on August 17, 2026 for $4.39 per share.

Dan Spaulding, Chief People Officer of Zillow Group, Inc., sold 5,135 shares of common stock on August 13, 2026.

David Linetsky, President, Network Solutions of Phreesia, Inc., reported a transaction in 182 shares of common stock on August 14, 2026.

Alastair Garfield, Chief Scientific Officer of Rhythm Pharmaceuticals, Inc., sold 7,763 shares of common stock on August 13, 2026.

Jeremy Hofmann, COO & CFO of Zillow Group, Inc., sold 9,171 shares of common stock on August 13, 2026.

Jeremy Wacksman, Chief Executive Officer and a Director of Zillow Group, Inc., sold 15,125 shares of common stock on August 13, 2026.

Conor B Tierney, Treasurer & CFO of AEye, Inc., reported a transaction in 26,549 shares of common stock on August 15, 2026.

Shiraz Shabanali Ladiwala, a Director of Mesa Laboratories Inc /Co/, reported multiple transactions in common stock on August 15, 2026.

Cynthia L Feldmann, a Director of Ufp Technologies Inc, sold 1,000 shares of common stock on August 13, 2026 for $324.26 per share.

Gaurav Shah, CEO of Rocket Pharmaceuticals, Inc., sold 2,837 shares of common stock on August 13, 2026 for $3.38 per share.

Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc., sold 3,493 shares of common stock on August 13, 2026 for $3.38 per share.

DST Global Advisors Ltd and 3 others reported changes in beneficial ownership of Chime Financial, Inc. common stock on August 13, 2026.

Amir Shojaei, CHIEF SCIENTIFIC OFFICER of Harrow, Inc., sold 11,250 shares of common stock on August 14, 2026 for $40.00 per share.

Ryan R. Caswell, CEO of Cannae Holdings, Inc., reported multiple transactions in common stock on August 13, 2026.

Alan K Shepard, President & CEO and a Director of CNX Resources Corp, reported multiple transactions in common stock on August 13, 2026.

Mark Christopher Brazier, Chief Financial Officer of Forward Industries, Inc., received 137,500 shares of common stock on August 8, 2026.

Shannon Hall, a Director of Mesa Laboratories Inc /Co/, reported multiple transactions in common stock on August 15, 2026.

DST Global Advisors Ltd and 9 others reported changes in beneficial ownership of Chime Financial, Inc. common stock on August 13, 2026.

Navneet Behl, Chief Operating Officer of CNX Resources Corp, reported multiple transactions in common stock on August 13, 2026.

Dennis Howard, MD, Chief Tech, OPS & Data Off of Schwab Charles Corp, sold 2,198 shares of common stock on August 13, 2026 for $110.00 per share.